Lipidio Pharma is focused on advancing a molecule to treat multiple dermatological diseases, including acne and sebaceous hyperplasia, as well as certain metabolic diseases such as nonalcoholic steatohepatitis (NASH) and obesity, which represent major unmet medical needs.